0000897069-24-002015.txt : 20241022 0000897069-24-002015.hdr.sgml : 20241022 20241022211233 ACCESSION NUMBER: 0000897069-24-002015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241018 FILED AS OF DATE: 20241022 DATE AS OF CHANGE: 20241022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yamashita Dennis CENTRAL INDEX KEY: 0002039412 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 241387625 MAIL ADDRESS: STREET 1: 10500 UNIVERSITY CENTER DRIVE STREET 2: SUITE 110 CITY: TAMPA STATE: FL ZIP: 33612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kintara Therapeutics, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130123 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 form4.xml X0508 4 2024-10-18 0001498382 Kintara Therapeutics, Inc. KTRA 0002039412 Yamashita Dennis 10500 UNIVERSITY CENTER DRIVE SUITE 110 TAMPA FL 33612 true Chief Scientific Officer false Options (Right to Buy) 3.69 2024-10-18 4 A 0 196790 0 A 2034-01-19 Common Stock 196790 196790 D Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), among the Issuer (fka "Kintara Therapeutics, Inc."), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer ("Merger Sub"), and TuHURA Biosciences, Inc., a Delaware corporation ("Private TuHURA"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the "Merger") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to "TuHURA Biosciences, Inc." One-third of the stock options become exercisable on the first, second, and third anniversary of January 19, 2024. /s/ Dan Dearborn as Power of Attorney for Dennis Yamashita 2024-10-22